Retina Biomarkers for Treatment Selection in DME

• by Kailynn M. Barton, BS, Muhammad Abidi, BS, Rajiv M. Sastry, BA, John B. Miller, MD

• May 1, 2026

Investigational OCTA Devices Show Promise in Diabetic Disease Assessment

At Retina World Congress, Patricio G. Schlottmann, MD, discussed investigational widefield OCTA platforms made by Chinese company TowardPi Medical.

• by Patricio G. Schlottmann, MD, Patricio G. Schlottmann, MD

• May 14, 2026

• 2 min

From risk factors to molecular targets: clinical associations and molecular docking insights into phthalate-associated diabetic retinopathy

• by Zhiwei Xu, Shi Bai, Caidi He, Xiaobei Lv, Qin Li, Qile Mao, Haijian Wu, Peter Wang

• May 13, 2026

AACE 2026: Will AI replace endocrinologists?

The same technology drawing patients away from clinic may also improve the patient-physician relationship.

• by Jared Bilski

• April 22, 2026

• 3 min